Patents by Inventor J. Eric CARLSON

J. Eric CARLSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
    Publication number: 20180354939
    Abstract: Embodiments of the disclosure relate to selectively substituted quinolone compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 13, 2018
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: J. Eric Carlson, Hans Hansen, Lynn Hawkins, Sally Ishizaka, Matthew Mackey, Shawn Schiller, Chikako Ogawa, Heather Davis, Atsushi Endo
  • Selectively substituted quinoline compounds
    Patent number: 10087174
    Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: October 2, 2018
    Assignee: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: J. Eric Carlson, Lynn Hawkins, Sally Ishizaka, Shawn Schiller, Chikako Ogawa, Atsushi Endo
  • SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
    Publication number: 20180030045
    Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Application
    Filed: August 7, 2017
    Publication date: February 1, 2018
    Applicant: EISAI R&D MANAGEMENT CO., LTD.
    Inventors: J. Eric CARLSON, Hans HANSEN, Lynn HAWKINS, Sally ISHIZAKA, Matthew MACKEY, Shawn SCHILLER, Chikako OGAWA, Heather DAVIS, Atsushi ENDO
  • Selectively substituted quinoline compounds
    Patent number: RE47193
    Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: January 8, 2019
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: J. Eric Carlson, Hans Hansen, Lynn Hawkins, Sally Ishizaka, Matthew Mackey, Shawn Schiller, Chikako Ogawa, Heather Davis, Atsushi Endo